AIMS: Nonkeratinizing morphology in oropharyngeal squamous cell carcinoma (NKSCC) strongly correlates with human papillomavirus and p16 status, but as a unique diagnostic entity is not widely recognized by pathologists. We sought to prospectively examine the performance of a new histological typing system during 1 year of routine clinical practice (Aim 1) and also its reproducibility amongst six head and neck pathologists using a 40 case test set (Aim 2). METHODS AND RESULTS: The three histological types were: Type 1 (keratinizing), Type 2 (nonkeratinizing with maturation) and Type 3 (nonkeratinizing). For Aim 1, there were 85 cases. p16 immunohistochemistry was positive in five of the 18 (27.8%) cases classified as Type 1, 18 of the 19 (94.7%) as Type 2, and 47 of the 48 (97.9%) as Type 3. For Aim 2, agreement among pathologists on the test cases was best for types 1 and 3 (kappa values 0.62 and 0.56; P < 0.0001) and lowest for type 2 (kappa 0.35; P < 0.0001). All 21 cases classified as NK SCC (type 3) by any of the reviewers was p16 positive. CONCLUSIONS: Pathologists can recognize NK SCC with good agreement, and when a pathologist classifies a tumour as NK SCC, this reliably predicts p16 positivity.
AIMS: Nonkeratinizing morphology in oropharyngeal squamous cell carcinoma (NKSCC) strongly correlates with human papillomavirus and p16 status, but as a unique diagnostic entity is not widely recognized by pathologists. We sought to prospectively examine the performance of a new histological typing system during 1 year of routine clinical practice (Aim 1) and also its reproducibility amongst six head and neck pathologists using a 40 case test set (Aim 2). METHODS AND RESULTS: The three histological types were: Type 1 (keratinizing), Type 2 (nonkeratinizing with maturation) and Type 3 (nonkeratinizing). For Aim 1, there were 85 cases. p16 immunohistochemistry was positive in five of the 18 (27.8%) cases classified as Type 1, 18 of the 19 (94.7%) as Type 2, and 47 of the 48 (97.9%) as Type 3. For Aim 2, agreement among pathologists on the test cases was best for types 1 and 3 (kappa values 0.62 and 0.56; P < 0.0001) and lowest for type 2 (kappa 0.35; P < 0.0001). All 21 cases classified as NK SCC (type 3) by any of the reviewers was p16 positive. CONCLUSIONS: Pathologists can recognize NK SCC with good agreement, and when a pathologist classifies a tumour as NK SCC, this reliably predicts p16 positivity.
Authors: Claude A Fischer; Inti Zlobec; Edith Green; Simone Probst; Claudio Storck; Alessandro Lugli; Luigi Tornillo; Markus Wolfensberger; Luigi M Terracciano Journal: Int J Cancer Date: 2010-03-01 Impact factor: 7.396
Authors: Joel A Ernster; Cosimo G Sciotto; Maureen M O'Brien; Jack L Finch; Linda J Robinson; Thomas Willson; Michael Mathews Journal: Laryngoscope Date: 2007-12 Impact factor: 3.325
Authors: Jason T Rich; Simon Milov; James S Lewis; Wade L Thorstad; Douglas R Adkins; Bruce H Haughey Journal: Laryngoscope Date: 2009-09 Impact factor: 3.325
Authors: Bhavna Kumar; Kitrina G Cordell; Julia S Lee; Francis P Worden; Mark E Prince; Huong H Tran; Gregory T Wolf; Susan G Urba; Douglas B Chepeha; Theodoros N Teknos; Avraham Eisbruch; Christina I Tsien; Jeremy M G Taylor; Nisha J D'Silva; Kun Yang; David M Kurnit; Joshua A Bauer; Carol R Bradford; Thomas E Carey Journal: J Clin Oncol Date: 2008-05-12 Impact factor: 44.544
Authors: Kathleen Settle; Marshall R Posner; Lisa M Schumaker; Ming Tan; Mohan Suntharalingam; Olga Goloubeva; Scott E Strome; Robert I Haddad; Shital S Patel; Earl V Cambell; Nicholas Sarlis; Jochen Lorch; Kevin J Cullen Journal: Cancer Prev Res (Phila) Date: 2009-07-29
Authors: Odey C Ukpo; Cedric V Pritchett; Jean E Lewis; Amy L Weaver; David I Smith; Eric J Moore Journal: Ann Otol Rhinol Laryngol Date: 2009-05 Impact factor: 1.547
Authors: Anders Näsman; Per Attner; Lalle Hammarstedt; Juan Du; Mathilda Eriksson; Geraldine Giraud; Sofie Ahrlund-Richter; Linda Marklund; Mircea Romanitan; David Lindquist; Torbjörn Ramqvist; Johan Lindholm; Pär Sparén; Weimin Ye; Hanna Dahlstrand; Eva Munck-Wikland; Tina Dalianis Journal: Int J Cancer Date: 2009-07-15 Impact factor: 7.396
Authors: David J Adelstein; John A Ridge; Maura L Gillison; Anil K Chaturvedi; Gypsyamber D'Souza; Patti E Gravitt; William Westra; Amanda Psyrri; W Martin Kast; Laura A Koutsky; Anna Giuliano; Steven Krosnick; Andy Trotti; David E Schuller; Arlene Forastiere; Claudio Dansky Ullmann Journal: Head Neck Date: 2009-11 Impact factor: 3.147
Authors: Fernando López; Michelle D Williams; Antonio Cardesa; Jennifer L Hunt; Primož Strojan; Alessandra Rinaldo; Iain J Nixon; Juan P Rodrigo; Nabil F Saba; William M Mendenhall; Miquel Quer; Carlos Suárez; Alfio Ferlito Journal: Eur Arch Otorhinolaryngol Date: 2017-03-31 Impact factor: 2.503
Authors: Ali Qureishi; Thomas Mawby; Lisa Fraser; Ketan A Shah; Henrik Møller; Stuart Winter Journal: Eur Arch Otorhinolaryngol Date: 2017-03-11 Impact factor: 2.503